Skip to content

Perioperative analgesia for elective total hip arthroplasty

Perioperative analgesia for elective total hip arthroplasty under subarachnoid anesthesia with opioids: comparison between epidural, femoral nerve block, FICB (fascia iliaca compartment block), femorocutaneous nerve block and psoas block techniques.

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618001474246
Enrollment
500
Registered
2018-09-03
Start date
2018-10-01
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Analgesia in total hip arthroplasty is important to reduce the incidence of postoperative chronic pain. This prospective, randomized trial compares several regional alternatives to subarachnoid anaesthesia (the most common technique). All of these interventions are widely used in routine clinical practice to improve analgesia, but there is not enough data to establish which of them is the most adequate to treat pain.

Interventions

Patients scheduled for total hip arthroplasty under spinal anesthesia enrolled during preoperative anesthesia consultation. Written informed consent obtained from all patients willing to participate in this study. All patients will receive subarachnoid anesthesia in the sitting position at L3–4 or L4–5 interspace, with a 25-gauge Whitacre needle. We administer 0.5% hyperbaric bupivacaine (Hyperbaric bupivacaine 0.5% 'Registered Trademark', Braun) according to the following formula: bupivacaine (

Patients scheduled for total hip arthroplasty under spinal anesthesia enrolled during preoperative anesthesia consultation. Written informed consent obtained from all patients willing to participate in this study. All patients will receive subarachnoid anesthesia in the sitting position at L3–4 or L4–5 interspace, with a 25-gauge Whitacre needle. We administer 0.5% hyperbaric bupivacaine (Hyperbaric bupivacaine 0.5% 'Registered Trademark', Braun) according to the following formula: bupivacaine (mg) = height (cm) x 0.07, with morphine (Morphine 0.1% 'Registered Trademark',, Braun) 0.15 mg and fentanyl (Fentanest 'Registered Trademark', Kern Pharma) 15 microg. Following injection, patients are immediately kept on lateral decubitus for 6 minutes to improve analgesia. There are 10 groups: - control group (without additional blocks). - epidural analgesia group (the subarachnoid anesthesia in these patients will be performed through the epidural needle at L3-4 or L4-5, the catheter advanced 3-4 cm and levobupivacaine (Chirocane 'Registered Trademark', Abbvie) 0.1% + fentanyl 2 microg.mL-1 (infusion rate 6-10 mL.h-1, bolus volume 5 mL, lock interval 30 min). Epidural infusion is started at the end of surgery. - femoral nerve block with 20 ml of levobupivacaine 0.375%, performed 7-10 minutes after spinal anesthesia, when the patient is placed supine again. - femoral block with 20 ml of levobupivacaine 0.375% and dexamethasone (Fortecortin 'Registered Trademark', Merck) 4 mg, performed 7-10 minutes after spinal anesthesia, when the patient is placed supine again. - Fascia Iliaca Compartment Block with 20 ml of levobupivacaine 0.375%, performed 7-10 minutes after spinal anesthesia, when the patient is placed supine again. - Fascia Iliaca Compartment Block with 20 ml of levobupivacaine 0.375% and dexamethasone 4 mg, performed 7-10 minutes after spinal anesthesia, when the patient is placed supine again. - Femorocutaneous nerve block with 10 ml of levobupivacaine 0.375%, performed 7-10 minutes after spinal anesthesia, when the patient is placed supine again. - Femorocutaneous nerve block with 20 ml of levobupivacaine 0.375% and dexamethasone 4 mg, performed 7-10 minutes after spinal anesthesia, when the patient is placed supine again. - Psoas block with 20 ml of levobupivacaine 0.375%, performed 7-10 minutes after spinal anesthesia, when the patient is placed supine again. - Psoas block with 20 ml of levobupivacaine 0.375% and dexamethasone 4 mg, performed 7-10 minutes after spinal anesthesia, when the patient is placed supine again. Surgeons and anesthesiologists are blinded to the addition of dexamethasone (perineural medication is prepared by a nurse adding 4 mg of dexamethasone or 1 ml of saline according to the randomized protocol). Nerve blocks are single-shots techniques performed under both ultrasound and nerve stimulation (considered adequate at 0.2-0.5 mA) by experienced anesthesiologists. All patients receive a standardized postoperative IV treatment: metamizole magnesium 8g/24 h, dexketoprofen 50 mg/12h. Postoperative analgesia begins immediately at the end of the surgery, when the patient is admitted to the PACU. The primary outcome, pain, is measured every hour (respecting the sleep period) during 24 h using a verbal rating 11–point scale for patient self-reporting of pain (VRS-11) previously explained to the patients: from 0 (“no pain”) to 10 (“the most horrible pain you can imagine; such as being burned alive”), and they are also advised to notify their nurse if they feel pain. Rescue analgesia when needed include: 1st: paracetamol 1 g, maximum 1g/6h/IV 2nd: Morphine 2 mg/15 min, maximum 10 mg/4h/IV Rescue blocks: FICB and epidural

Sponsors

Hospital Complex of Navarra (Complejo Hospitalario de Navarra)
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients scheduled for total hip arthroplasty

Exclusion criteria

unicompartmental hip arthroplasty, refusal to participate, contraindication to spinal or regional anesthesia and/or allergy to the drugs used

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026